iSpecimen EPS ISPC
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- −$52.84
- Latest quarter, Q2 FY26
- −$0.98
- Fiscal year 2025
- −$90.53
iSpecimen's earnings per share was −$52.84 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.98.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$90.53 | n/a |
| FY2024 | −$701.60 | n/a |
| FY2023 | −$985.20 | n/a |
| FY2022 | −$928.00 | n/a |
| FY2021 | −$4472.00 | n/a |
| FY2020 | −$3976.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.98 | n/a | −$52.84 | |
| Q1 FY26 | −$6.66 | n/a | −$68.64 | |
| Q4 FY25 | −$26.00 | n/a | −$90.53 | |
| Q3 FY25 | −$19.20 | n/a | −$278.93 | |
| Q2 FY25 | −$16.78 | n/a | −$343.73 | |
| Q1 FY25 | −$28.55 | n/a | −$475.75 | |
| Q4 FY24 | −$214.40 | n/a | −$701.60 | |
| Q3 FY24 | −$84.00 | n/a | −$758.00 | |
| Q2 FY24 | −$148.80 | n/a | −$860.40 | |
| Q1 FY24 | −$254.40 | n/a | −$1023.60 | |
| Q4 FY23 | −$270.80 | n/a | −$985.20 | |
| Q3 FY23 | −$186.40 | n/a | −$906.40 |
Against its peers
Companies in Healthcare nearest iSpecimen's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ISPCiSpecimen | −$52.84 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| Peer median | $0.19 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on iSpecimen
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.